Literature DB >> 22964475

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients.

Thomas U Ahearn1, Aasma Shaukat, W Dana Flanders, Robin E Rutherford, Roberd M Bostick.   

Abstract

APC/β-catenin pathway perturbation is a common early event in colorectal carcinogenesis and is affected by calcium and vitamin D in basic science studies. To assess the effects of calcium and vitamin D on adenomatous polyposis coli (APC), β-catenin, and E-cadherin expression in the normal appearing colorectal mucosa of sporadic colorectal adenoma patients, we conducted a randomized, double-blinded, placebo-controlled 2 × 2 factorial clinical trial. Pathology-confirmed colorectal adenoma cases were treated with 2 g/day elemental calcium and/or 800 IU/day vitamin D(3) versus placebo over 6 months (N = 92; 23/group). Overall APC, β-catenin, and E-cadherin expression and distributions in colon crypts in normal-appearing rectal mucosa biopsies were detected by standardized automated immunohistochemistry and quantified by image analysis. In the vitamin D(3)-supplemented group relative to placebo, the proportion of APC in the upper 40% of crypts (Φh APC) increased 21% (P = 0.01), β-catenin decreased 12% (P = 0.18), E-cadherin increased 72% (P = 0.03), and the Φh APC/β-catenin ratio (APC/β-catenin score) increased 31% (P = 0.02). In the calcium-supplemented group Φh APC increased 10% (P = 0.12), β-catenin decreased 15% (P = 0.08), and the APC/β-catenin score increased 41% (P = 0.01). In the calcium/vitamin D(3)-supplemented group, β-catenin decreased 11% (P = 0.20), E-cadherin increased 51% (P = 0.08), and the APC/β-catenin score increased 16% (P = 0.26). These results support (i) that calcium and vitamin D modify APC, β-catenin, and E-cadherin expression in humans in directions hypothesized to reduce risk for colorectal neoplasms, (ii) calcium and vitamin D as potential chemopreventive agents against colorectal neoplasms, and (iii) the potential of APC, β-catenin, and E-cadherin expression as modifiable, preneoplastic risk biomarkers for colorectal neoplasms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964475      PMCID: PMC3466388          DOI: 10.1158/1940-6207.CAPR-12-0292

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  38 in total

Review 1.  Wnt signaling: is the party in the nucleus?

Authors:  Karl Willert; Katherine A Jones
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

2.  Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.

Authors:  Edward D Gorham; Cedric F Garland; Frank C Garland; William B Grant; Sharif B Mohr; Martin Lipkin; Harold L Newmark; Edward Giovannucci; Melissa Wei; Michael F Holick
Journal:  Am J Prev Med       Date:  2007-03       Impact factor: 5.043

3.  Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers.

Authors:  B W Hollis
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 4.  Colorectal cancer: molecules and populations.

Authors:  J D Potter
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

5.  Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.

Authors:  Genoveva Murillo; Rajendra G Mehta
Journal:  J Steroid Biochem Mol Biol       Date:  2005-07-26       Impact factor: 4.292

6.  Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence.

Authors:  R M Day; X Hao; M Ilyas; P Daszak; I C Talbot; A Forbes
Journal:  Virchows Arch       Date:  1999-02       Impact factor: 4.064

7.  E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.

Authors:  Adam Elzagheid; Annika Algars; Riyad Bendardaf; Hanan Lamlum; Raija Ristamaki; Yrjo Collan; Kari Syrjanen; Seppo Pyrhonen
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

8.  Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3).

Authors:  Subhas Chakrabarty; Hongmei Wang; Lucie Canaff; Geoffrey N Hendy; Henry Appelman; James Varani
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

9.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.

Authors:  Joan M Lappe; Dianne Travers-Gustafson; K Michael Davies; Robert R Recker; Robert P Heaney
Journal:  Am J Clin Nutr       Date:  2007-06       Impact factor: 7.045

10.  Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer.

Authors:  B W Hollis; J Q Kamerud; A Kurkowski; J Beaulieu; J L Napoli
Journal:  Clin Chem       Date:  1996-04       Impact factor: 8.327

View more
  17 in total

1.  Association Between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas.

Authors:  Xiaosheng He; Kana Wu; Shuji Ogino; Edward L Giovannucci; Andrew T Chan; Mingyang Song
Journal:  Gastroenterology       Date:  2018-04-24       Impact factor: 22.682

2.  Associations of Calcium, Vitamin D, and Dairy Product Intakes with Colorectal Cancer Risk among Older Women: The Iowa Women's Health Study.

Authors:  Caroline Y Um; Anna Prizment; Ching-Ping Hong; DeAnn Lazovich; Roberd M Bostick
Journal:  Nutr Cancer       Date:  2018-12-20       Impact factor: 2.900

Review 3.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

Review 4.  Vitamin D and colon cancer.

Authors:  Lidija Klampfer
Journal:  World J Gastrointest Oncol       Date:  2014-11-15

Review 5.  Effects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasms.

Authors:  Roberd M Bostick
Journal:  J Steroid Biochem Mol Biol       Date:  2015-01-15       Impact factor: 4.292

6.  Inhibition of 4-nitroquinoline-1-oxide-induced oral carcinogenesis by dietary calcium.

Authors:  Yi Jiang; Liyan Liao; Chandrama Shrestha; Daiqiang Li; Meirong Li; Ying Mu; Debra Crumrine; Larry Wang; Zhongjian Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

7.  Calcium intake and colorectal cancer risk: Results from the nurses' health study and health professionals follow-up study.

Authors:  Xuehong Zhang; NaNa Keum; Kana Wu; Stephanie A Smith-Warner; Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-08-09       Impact factor: 7.396

8.  Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants.

Authors:  Marianna Sarkissyan; Yanyuan Wu; Zujian Chen; Dhruva K Mishra; Suren Sarkissyan; Ioannis Giannikopoulos; Jaydutt V Vadgama
Journal:  Cancer       Date:  2014-02-07       Impact factor: 6.860

9.  Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study.

Authors:  Xiangzhu Zhu; Ji Liang; Martha J Shrubsole; Reid M Ness; Qiuyin Cai; Jirong Long; Zhi Chen; Guoliang Li; Dawn Wiese; Bing Zhang; Walter E Smalley; Todd L Edwards; Edward Giovannucci; Wei Zheng; Qi Dai
Journal:  J Nutr       Date:  2014-08-27       Impact factor: 4.798

10.  Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients.

Authors:  Siyu Liu; Elizabeth L Barry; John A Baron; Robin E Rutherford; March E Seabrook; Roberd M Bostick
Journal:  Mol Carcinog       Date:  2016-06-14       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.